Aurora Cannabis announced its financial and operational results for Q1 2026. Total net revenue was $98 million, as compared to $83.4 million in the prior year period. The 17 per cent increase from the prior year period was mainly due to 37 per cent growth in our global medical cannabis business and 4 per cent growth in our plant propagation business.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Curaleaf reports Q2 2025 results: Domestic stabilization, robust international momentum
2 | Cresco Labs solid Q2 performance and debt refinancing strengthen foundation for long-term value creation
3 | Cronos Group reports Q2 2025 results, boasting by 21 per cent net revenue year-over-year increase
4 | The Cannabist Company reports Q2 2025 results
Top Cannabis Stocks Aug. 1 to Aug. 7, 2025
1. T.TLRY | 8,445 views | Tilray Brands Inc.
2. T.LABS | 5,009 views | Medipharm Labs Corp.
3. T.CURA | 4,354 views | Curaleaf Holdings Inc.
4. T.WEED | 2,365 views | Canopy Growth Corp.
5. T.ACB | 649 views | Aurora Cannabis Inc.
6. T.OGI | 534 views | Organigram Holdings Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
